Literature DB >> 31232364

Key points to consider in the IMPERIAL trial.

Jim A Reekers1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31232364     DOI： 10.1016/S0140-6736(19)30693-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  The Challenges of New Endovascular Technologies.

Authors:  Jim A Reekers
Journal:  CVIR Endovasc       Date:  2019-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.